Background illustration for clinical trials search

Uterine Cancer Clinical Trials

Browse 349 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer

for
Endometrial Cancer
Location: Lexington KY
Sponsor: Rachel Miller

Sex: Female

Age: 18+

Code: NCT06677112

Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Boston MA, Providence RI, Lebanon NH, Quebec,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Scarborough ME, Providence RI, Manchester CT,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

for
Endometrial Cancer
Location: Buffalo NY, Pittsburgh PA, Orlando FL, Tampa FL,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: Female

Age: 18 - 70

Code: NCT06481592

Phase 2, Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

for
Cervical Cancer
Location: Providence RI, Brooklyn NY, Voorhees Township NJ,
Sponsor: Pfizer

Sex: Female

Age: 18+

Code: NCT06952660

Phase 4, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

for
Congenital Uterine Anomaly
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 13+

Code: NCT04661072

Recruiting

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

for
Uterine Cervical Neoplasms
Location: Washington D.C. DC
Sponsor: ISA Associates, Inc.

Sex: Female

Age: 21 - 65

Code: NCT07011836

Recruiting

Uterine Lavage to Detect Ovarian Cancer Risk

for
BRCA Hereditary Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Female

Age: 18+

Code: NCT07772869

Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

for
Ovarian Neoplasms, Ovarian Epithelial Carcinoma,
Location: Boston MA, Annapolis MD, Baltimore MD, Little Rock AR,
Sponsor: Massachusetts General Hospital

Sex: Female

Age: 30+

Code: NCT04794322

Recruiting
New

CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M),
Location: Fairfax VA, Dallas TX, Austin TX
Sponsor: Crescent Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07909031

Phase 1, Phase 2, Recruiting
New

A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Orlando FL, Fort Worth TX, Fountain Valley CA
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07743164

Phase 3, Recruiting
New

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

for
Head and Neck Cancer, Non-Small Cell Lung Cancer,
Location: Lexington KY
Sponsor: Mark Bernard

Sex: All

Age: 18 - 70+

Code: NCT07770100

Phase 2, Recruiting

A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors

for
Squamous Non-small-cell Lung Cancer,
Location: Hackensack NJ, Fairfax VA, Chicago IL, Scottsdale AZ,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT06747585

Phase 1, Phase 2, Recruiting

A Study of VET3-TGI in Patients With Solid Tumors

for
Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer,
Location: Miami FL, Pittsburgh PA, Indianapolis IN, Houston TX,
Sponsor: KaliVir Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06444815

Phase 1, Recruiting

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

for
Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT05429970

Recruiting

ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Pittsburgh PA
Sponsor: Alexander B Olawaiye, MD

Sex: Female

Age: 18+

Code: NCT05071937

Phase 2, Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Boston MA, New Haven CT, New York NY,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase 1, Recruiting

Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer

for
Renal Tumor Histology, Cutaneous Leiomyoma, Kidney Cancer
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2+

Code: NCT00050752

Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Boston MA, New Haven CT, New Brunswick NJ, Montreal,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase 2, Recruiting

Avera Cancer Sequencing and Analytics Protocol (ASAP)

for
Cancer, Cancer Diagnosis, Early Detection of Cancer,
Location: Marshall MN, Sioux Falls SD, Yankton SD, Mitchell SD,
Sponsor: Avera McKennan Hospital & University Health Center

Sex: All

Age: 18+

Code: NCT05142033

Recruiting